Search for: "RANBAXY INC" Results 1 - 20 of 93
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Jun 2008, 4:39 am
AP reports: Pfizer Inc. and India's Ranbaxy Laboratories Ltd. said June 18 they have settled their patent dispute over the blockbuster cholesterol drug Lipitor, delaying the release of generic versions in the U.S. until Nov. 30, 2011.Forbes gave a more complete account of the event, and noted an immediate drop in Ranbaxy stock of 5%:Under the terms of the agreement, Ranbaxy will have a license to sell generic versions of Lipitor and Caduet in the United… [read post]
8 Nov 2007, 8:01 pm
By Sherri Oslick -- Ranbaxy Laboratories, Astellas Pharma US, Inc., and Boehringer Ingelheim Corporation have announced their agreement to enter into a joint stipulation of dismissal without prejudice in their lawsuit over FLOMAX ® (tamsulosin hydrochloride, used to treat benign prostatic hyperplasia). [read post]
1 Dec 2011, 3:58 am by Lawrence B. Ebert
Yes, Virginia, Ranbaxy Will Sell A Generic Lipitor Ranbaxy to Share Part of Lipitor Profits With Teva**UPDATE. [read post]
2 Jan 2013, 6:50 pm by FDABlog HPM
District Court for the District of Columbia granted both FDA’s and Intervenor-Defendant Ranbaxy Laboratories Limited’s (“Ranbaxy’s”) Motions for Summary Judgment and denied Mylan Laboratories Limited’s and Mylan Pharmaceuticals Inc. [read post]
13 May 2010, 9:59 pm by Patent Docs
Medicis argued further that Ranbaxy Inc. aided, abetted,... [read post]
8 Aug 2010, 8:32 pm by Patent Docs
Ranbaxy Laboratories Ltd. et al. 2:10-cv-03897; filed August 4, 2010 in the Eastern District of Pennsylvania • Plaintiff: Lupin Atlantis Holdings S.A. • Defendants: Ranbaxy Laboratories Ltd.; Ranbaxy Pharmaceuticals Inc.; Ranbaxy, Inc.; Ethypharm S.A. [read post]
27 Nov 2012, 2:57 am by Robert Kraft
(RBXY) fell the most in more than three months after announcing a recall of the company’s generic version of Pfizer Inc. [read post]
14 May 2013, 10:50 am
Ranbaxy USA Inc., the American subsidiary of Ranbaxy Laboratories Limited, an Indian generic pharmaceutical maker, has agreed to pay $500 million to settle fines related to claims that it made false statements to the FDA about its manufacturing practices abroad and sold substandard medications and pay penalties. [read post]
23 Nov 2012, 10:40 am
Indian drugmaker Ranbaxy Laboratories said it issued the recall because of its generic version of Pfizer Inc.' [read post]
21 May 2013, 2:26 pm by Fraud Fighters
Earlier this month, the Department of Justice announced a $500 million settlement it reached with Ranbaxy USA Inc., a subsidiary of the Indian generic pharmaceutical manufacturer Ranbaxy Laboratories Limited. [read post]
1 Dec 2012, 8:00 pm by Lawrence B. Ebert
Separately, as to Ranbaxy's version of Lipitor ( atorvastatin ), note text from BusinessWeek in the postDrugmaker Ranbaxy halts generic Lipitor production : Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into the ingredients used for dozens of batches of the drug that were recalled in November. [read post]
5 Oct 2016, 2:21 pm by Law360
Direct and indirect buyers of the heartburn medication Nexium asked a First Circuit panel for another shot at a pay-for-delay class action against AstraZeneca PLC and Ranbaxy Inc., arguing that the trial judge's erroneous summary judgment and evidentiary rulings tainted the verdict. [read post]
14 Jun 2009, 8:17 pm
Ranbaxy Inc. et al. 1:09-cv-00435; filed June 11, 2009 in the District Court of Delaware Infringement of U.S. [read post]